X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with Glenmark Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs GLENMARK PHARMA - Comparison Results

GLENMARK PHARMA 
   Change

Glenmark's focus areas are dermatology, gynecology, pediatrics and diabetics. The domestic formulations business contributed about 35% to revenues in FY07. On the international front, besides exports to the semi-regulated markets, the company has bee... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. GLENMARK PHARMA FDC LTD./
GLENMARK PHARMA
 
P/E (TTM) x 24.9 19.9 125.0% View Chart
P/BV x 5.0 3.6 139.1% View Chart
Dividend Yield % 1.0 0.3 281.8%  

Financials

 FDC LTD.   GLENMARK PHARMA
EQUITY SHARE DATA
    FDC LTD.
Mar-14
GLENMARK PHARMA
Mar-17
FDC LTD./
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs144993 14.5%   
Low Rs79729 10.8%   
Sales per share (Unadj.) Rs47.6325.5 14.6%  
Earnings per share (Unadj.) Rs7.639.3 19.4%  
Cash flow per share (Unadj.) Rs9.048.7 18.5%  
Dividends per share (Unadj.) Rs2.252.00 112.5%  
Dividend yield (eoy) %2.00.2 870.8%  
Book value per share (Unadj.) Rs47.5159.2 29.9%  
Shares outstanding (eoy) m177.83282.17 63.0%   
Bonus/Rights/Conversions BBESOP-  
Price / Sales ratio x2.32.6 88.4%   
Avg P/E ratio x14.621.9 66.7%  
P/CF ratio (eoy) x12.317.7 69.8%  
Price / Book Value ratio x2.35.4 43.3%  
Dividend payout %29.65.1 580.9%   
Avg Mkt Cap Rs m19,784242,991 8.1%   
No. of employees `000NA13.0 0.0%   
Total wages/salary Rs m1,22116,408 7.4%   
Avg. sales/employee Rs ThNM7,083.9-  
Avg. wages/employee Rs ThNM1,265.4-  
Avg. net profit/employee Rs ThNM855.1-  
INCOME DATA
Net Sales Rs m8,45991,857 9.2%  
Other income Rs m394374 105.3%   
Total revenues Rs m8,85292,230 9.6%   
Gross profit Rs m2,07020,367 10.2%  
Depreciation Rs m2492,644 9.4%   
Interest Rs m312,373 1.3%   
Profit before tax Rs m2,18415,724 13.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m0-810 0.0%   
Tax Rs m6063,827 15.8%   
Profit after tax Rs m1,35311,088 12.2%  
Gross profit margin %24.522.2 110.4%  
Effective tax rate %27.724.3 113.9%   
Net profit margin %16.012.1 132.5%  
BALANCE SHEET DATA
Current assets Rs m4,35568,746 6.3%   
Current liabilities Rs m1,79227,027 6.6%   
Net working cap to sales %30.345.4 66.7%  
Current ratio x2.42.5 95.6%  
Inventory Days Days4485 52.3%  
Debtors Days Days2596 25.8%  
Net fixed assets Rs m3,02524,132 12.5%   
Share capital Rs m179282 63.3%   
"Free" reserves Rs m8,24344,643 18.5%   
Net worth Rs m8,45344,925 18.8%   
Long term debt Rs m1145,363 0.0%   
Total assets Rs m10,557117,639 9.0%  
Interest coverage x71.47.6 936.5%   
Debt to equity ratio x01.0 0.1%  
Sales to assets ratio x0.80.8 102.6%   
Return on assets %13.111.4 114.6%  
Return on equity %16.024.7 64.9%  
Return on capital %23.519.1 122.8%  
Exports to sales %13.30-   
Imports to sales %3.30-   
Exports (fob) Rs m1,126NA-   
Imports (cif) Rs m283NA-   
Fx inflow Rs m1,14656,152 2.0%   
Fx outflow Rs m3558,084 4.4%   
Net fx Rs m79148,068 1.6%   
CASH FLOW
From Operations Rs m1,4856,574 22.6%  
From Investments Rs m-620-7,124 8.7%  
From Financial Activity Rs m-7535,432 -13.9%  
Net Cashflow Rs m1131,992 5.7%  

Share Holding

Indian Promoters % 68.9 48.3 142.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 6.9 68.1%  
FIIs % 7.5 34.4 21.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 10.5 181.0%  
Shareholders   23,730 56,727 41.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   J.B.CHEMICALS  ALEMBIC LTD  CIPLA  AJANTA PHARMA  SUVEN LIFE  

Compare FDC LTD. With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day in Green; Metal Stocks Top Gainers(Closing)

After opening the day in green, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views on News

GLENMARK PHARMA Announces Quarterly Results (4QFY18); Net Profit Down 6.6%

May 31, 2018 | Updated on May 31, 2018

For the quarter ended March 2018, GLENMARK PHARMA has posted a net profit of Rs 2 bn (down 6.6% YoY). Sales on the other hand came in at Rs 23 bn (down 7.2% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

Glenmark: Zetia Bolsters Sales and Profits (Quarterly Results Update - Detailed)

Oct 30, 2017

The 180-day exclusivity for Zetia enabled Glenmark to show strong growth in sales and profits during the quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Jun 20, 2018 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE FDC LTD. WITH

MARKET STATS